Biography:Saurabh Saha
Saurabh Saha | |
---|---|
Nationality | American |
Education | BSc, MSc, MD, and PhD |
Alma mater | California Institute of Technology Johns Hopkins University Harvard University University of Oxford |
Occupation | Cancer drug discovery |
Known for | Translational medicine Cancer biosurgery |
Saurabh Saha is an American biotech entrepreneur.[1]
Education
Saha received his undergraduate degree in biology from the California Institute of Technology.[2] He also attended both Harvard Business School and Oxford University.[3] Saha trained under Bert Vogelstein during his studies at the Johns Hopkins School of Medicine,[4] where he received both an MD and a PhD in cancer genetics.[5]
Career
After finishing graduate school, Saha joined the management consulting firm McKinsey & Company in their Pharmaceuticals and Medical Products Practice in New York City.[6] In 2005, he became the Director of the New Indications Discovery Unit at the Novartis Institutes for BioMedical Research based in Cambridge, Massachusetts.[5] Between 2008 and 2015, Saha served as the President of BioMed Valley Discoveries[7] [3] Saha serves as a venture partner for the life sciences venture capital firm, Atlas Venture and also served as the Chief Medical Officer for its portfolio company, Synlogic.[8]
In 2016, Saha was appointed as President and CEO of Delinia, a biotech company focused on developing novel therapies for the treatment of cancer and autoimmune diseases such as lupus, inflammatory bowel disease, rheumatoid arthritis and others.[9] [10] [11]
Saha has published in periodicals where he and his colleagues reported translational research and development discoveries in cancer research.[12][13][14][15][16][17][18] He is also on the editorial boards of the American Journal of Clinical Oncology,[19] Journal of Translational Medicine,[20] and Cancer Biology & Therapy.[21]
References
- ↑ "Executive Profile". Bloomberg. https://www.bloomberg.com/research/stocks/private/person.asp?personId=272235659&privcapId=379797415.
- ↑ "Commencement". http://caltechcampuspubs.library.caltech.edu/2482/1/June_13,_1997.pdf. Retrieved September 19, 2014.
- ↑ 3.0 3.1 "Saurabh Saha". http://biomed-valley.com/management. Retrieved September 15, 2014.
- ↑ Alice Park (August 13, 2014). "Treating Cancer With Bacteria Shows Real Promise". Time Magazine. http://time.com/3107896/bacteria-cancer-tumor/. Retrieved September 15, 2015.
- ↑ 5.0 5.1 "Saurabh Saha". http://canceradvance.com/speaker/saurabh-saha/. Retrieved September 15, 2014.
- ↑ "Biomed Valley Discoveries". http://www.stowers.org/stowers-report/spring-2013/biomed-valley-discoveries. Retrieved September 19, 2014.
- ↑ Mitch Leslie (August 13, 2014). "Bacteria shrink tumors in humans, dogs". Science Magazine. https://www.science.org/content/article/bacteria-shrink-tumors-humans-dogs. Retrieved September 15, 2014.
- ↑ Fidler, Ben (September 14, 2016). "Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases". Xconomy. http://www.xconomy.com/boston/2016/09/14/sofinnova-atlas-put-35m-into-delinia-to-tackle-autoimmune-diseases/#.
- ↑ Carroll, John (September 14, 2016). "Atlas Partner Saha Takes the Helm at Delinia, Looking to Disrupt Autoimmune R&D". Endpoints News. https://endpts.com/atlas-partner-saha-takes-the-helm-at-delinia-looking-to-disrupt-autoimmune-rd/.
- ↑ Adams, Ben (January 26, 2017). "Celgene Splashes Out $300M on Delinia Autoimmune Biotech Buy". FierceBiotech. http://www.fiercebiotech.com/biotech/celgene-splashes-out-300m-delinia-autoimmune-biotech-buy.
- ↑ Gormley, Brian (January 26, 2017). "Celgene to Pay Up to $775 Million to Buy Biotech Startup Delinia". The Wall Street Journal. https://www.wsj.com/articles/celgene-to-pay-up-to-775-million-to-buy-biotech-startup-delinia-1485439414.
- ↑ Saha S; Sparks AB; Rago C; Akmaev V; Wang CJ; Vogelstein B; Kinzler KW; Velculescu VE (May 2002). "Using the transcriptome to annotate the genome". Nature Biotechnology 20 (5): 508–12. doi:10.1038/nbt0502-508. PMID 11981567.
- ↑ Christoph Lengauer; Luis A. Diaz, Jr; Saurabh Saha (May 2005). "Outlook: Cancer drug discovery through collaboration". Nature Reviews Drug Discovery 4 (5): 375–380. doi:10.1038/nrd1722. PMID 15864266.
- ↑ Saurabh Saha (October 11, 2001). "A Phosphatase Associated with Metastasis of Colorectal Cancer". Science 294 (5545): 1343–1346. doi:10.1126/science.1065817. PMID 11598267. https://www.science.org/doi/abs/10.1126/science.1065817?sid=4146d36a-c726-4cb8-a792-96c0198bc6d8. Retrieved September 15, 2014.
- ↑ Bardelli, Alberto; Parsons, D. Williams; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Saha, Saurabh; Markowitz, Sanford; Willson, James K. V. et al. (May 2003). "Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers". Science 300 (5621): 949. doi:10.1126/science.1082596. PMID 12738854. https://www.science.org/doi/abs/10.1126/science.1082596.
- ↑ Roberts, Nicholas J. et al. (Aug 2014). "Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses". Science Translational Medicine 6 (249). doi:10.1126/scitranslmed.3008982. PMID 25122639.
- ↑ Bardelli, Alberto; Parsons, D. Williams; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Saha, Saurabh; Markowitz, Sanford; Willson, James K. V. et al. (9 May 2003). "Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers". Science 300 (5621): 949. doi:10.1126/science.1082596. PMID 12738854.
- ↑ Roberts, Nicholas J.; Zhang, Linping; Janku, Filip; Collins, Amanda; Bai, Ren-Yuan; Staedtke, Verena; Rusk, Anthony W.; Tung, David et al. (13 August 2014). "Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses". Science Translational Medicine 6 (249): 249ra111. doi:10.1126/scitranslmed.3008982. PMID 25122639.
- ↑ "Editorial board". http://journals.lww.com/amjclinicaloncology/pages/editorialboard.aspx. Retrieved September 15, 2014.
- ↑ "Editorial board". http://www.translational-medicine.com/edboard. Retrieved September 15, 2014.
- ↑ "Editorial board". http://www.landesbioscience.com/journals/cbt/editorialboard/. Retrieved September 15, 2014.
![]() | Original source: https://en.wikipedia.org/wiki/Saurabh Saha.
Read more |